NFV is manufactured by Roche and is used to treat HIV/AIDS. ## Compulsory licenses Compulsory licenses have been issued for NFV in the following instance: ### Brazil issued on August 01, 2001 [[Brazil]]'s provisions on compulsory licences can be in the Industrial Property Law (Law No. 9,279/1996). A compulsory licence may be granted under the following grounds: - Non-working or insufficient working If the patented invention is not being worked (i.e., not being utilised/manufactured) in Brazil or is not meeting domestic demand. - Refusal to grant licences on reasonable terms The applicant must have asked for a licence from the patent holder under reasonable terms and been unable to obtain one. - Public interest / national emergency / anti-competitive practice / government use The law allows the government (or Tribunal) to issue compulsory licences for patents covering inventions (products or processes) which are declared to be of “vital importance” to public interest, public health, economy, etc. More information can be found [here](https://www.wipo.int/wipolex/en/legislation/details/23216 ). However, a compulsory license has not been executed for NFV in this case because: a price discount was issued. ## Other products issued by the same manufacturer [[Erlotinib]] [[Oseltamivir]] [[NFV]] [[T-20]] [[Trastuzumab-Emtansine]] [[Pertuzumab]] ## Other products for the same disease [[ARVs]] [[All medicines]] [[EFV]] [[Dolutegravir]] [[3TC/D4T/NVP]] [[EFV/FTC/TDF, 3TC/AZT/EFV]] [[RTV]] [[NVP, 3TC, 3TC/AZT]] [[ARVs +]] [[AZT]] [[T-20]] [[DDI, IDV, LPV/r]] [[3TC/AZT/NVP]] [[LPV/r]] [[IDV, LPV/r, NVP, TDF]] [[AZT, 3TC, D4T, NVP, 3TC/AZT]] [[NVP, AZT]] [[3TC/AZT]] [[3TC, D4T, AZT, NVP, EFV, TDF, DDI, LPV/r, SQV, RTV, NFV, ABC]] [[ATV]] [[NVP]] [[ABC/3TC]] [[3TC]] [[3TC, NVP, AZT]] [[NVP, 3TC]] [[3TC, 3TC/AZT, 3TC/AZT/NVP, 3TC/D4T, 3TC/D4T/NVP, DDI, EFV, IDV]] [[AZT, 3TC, AZT/3TC, NVP]] [[RAL]] [[EFV, NVP, 3TC/AZT]] [[3TC/D4T/NVP, LPV/r]] [[TDF/3TC]] [[AZT, 3TC+AZT]]